GHTC Breakthroughs Blog

Research Roundup: J&J vaccine authorized by FDA, COVAX starts African rollout, vaccine makers evaluate boosters

U.S. Secretary of Defense

March 1, 2021

Research Roundup: J&J vaccine authorized by FDA, COVAX starts African rollout, vaccine makers evaluate boosters

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Anna Kovacevich GHTC

Research Roundup: Pfizer seeks update to vaccine cold storage requirements, first vaccine trial in pregnant women begins, and AstraZeneca vaccine authorized by WHO

Flickr/Chairman of the Joint Chiefs of Staff

February 22, 2021

Research Roundup: Pfizer seeks update to vaccine cold storage requirements, first vaccine trial in pregnant women begins, and AstraZeneca vaccine authorized by WHO

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Anna Kovacevich GHTC

Research Roundup: AstraZeneca vaccine receives use recommendations, Eli Lilly antibody authorized by FDA, and an anti-inflammatory drug cuts deaths in trial

PATH/Eric Becker

February 15, 2021

Research Roundup: AstraZeneca vaccine receives use recommendations, Eli Lilly antibody authorized by FDA, and an anti-inflammatory drug cuts deaths in trial

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Anna Kovacevich GHTC

Research Roundup: Vaccines to undergo regulatory review, COVAX releases interim distribution plan, novel HIV vaccine approach shows promise in early trial

PATH/Rocky Prajapati

February 8, 2021

Research Roundup: Vaccines to undergo regulatory review, COVAX releases interim distribution plan, novel HIV vaccine approach shows promise in early trial

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Anna Kovacevich GHTC

A new hope: How the WHO Executive Board meeting signaled the need for a global pivot for global health R&D

United States Mission Geneva

February 5, 2021

A new hope: How the WHO Executive Board meeting signaled the need for a global pivot for global health R&D

The 148th session of the World Health Organization Executive Board came to a close last week, signaling a potential pivot point for global health. As the world continues to battle a devastating pandemic, here's a look at how 2021 could present fresh opportunities to strengthen the global R&D ecosystem.

Philip Kenol GHTC

Research Roundup: J&J and Novavax release vaccine efficacy data, Regeneron drug provides

PATH/Aaron Joel Santos

February 1, 2021

Research Roundup: J&J and Novavax release vaccine efficacy data, Regeneron drug provides "passive vaccination" in trial

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Anna Kovacevich GHTC

Breakthroughs Blog

Breakthroughs brings you stories of bright ideas and bold innovations in global health.

From the Breakthroughs Blog: Page #2

Research Roundup: J&J vaccine authorized by FDA, COVAX starts African rollout, vaccine makers evaluate boosters

Research Roundup: Pfizer seeks update to vaccine cold storage requirements, first vaccine trial in pregnant women begins, and AstraZeneca vaccine authorized by WHO

Research Roundup: AstraZeneca vaccine receives use recommendations, Eli Lilly antibody authorized by FDA, and an anti-inflammatory drug cuts deaths in trial

Research Roundup: Vaccines to undergo regulatory review, COVAX releases interim distribution plan, novel HIV vaccine approach shows promise in early trial

A new hope: How the WHO Executive Board meeting signaled the need for a global pivot for global health R&D

Research Roundup: J&J and Novavax release vaccine efficacy data, Regeneron drug provides "passive vaccination" in trial